George Golumbeski serves as Executive at ENANTA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, George Golumbeski has executed 12 insider transactions totaling $2.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 31, 2025 involved transacting 8,000 shares valued at $0.
George Golumbeski currently holds 8,000 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Golumbeski has been a net seller of ENTA stock. They have purchased $451.4K and sold $2.2M worth of shares.
George Golumbeski's most recent insider trade was on Jul 31, 2025, when they sold 8,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $31.45 |
| Discretionary |
| Apr 26, 2022 | STTK | $102.8K | Purchase | 28,330 | $3.63 | Discretionary |
| Apr 22, 2022 | STTK | $859 | Purchase | 234 | $3.67 | Discretionary |
| Apr 21, 2022 | STTK | $96.1K | Purchase | 26,049 | $3.69 | Discretionary |
| Mar 4, 2019 | ENTA | $339.7K | Option Exercise | 9,280 | $36.61 | Discretionary |
| Mar 4, 2019 | ENTA | $961.9K | Sale | 9,280 | $103.65 | Discretionary |
| Feb 12, 2019 | ENTA | $95.4K | Option Exercise | 3,728 | $25.58 | Discretionary |
| Feb 12, 2019 | ENTA | $217.7K | Option Exercise | 7,500 | $29.02 | Discretionary |
| Feb 12, 2019 | ENTA | $1.0M | Sale | 11,228 | $90.07 | Discretionary |
| Feb 11, 2019 | ENTA | $204.5K | Sale | 2,272 | $90.03 | Discretionary |
| Feb 11, 2019 | ENTA | $58.1K | Option Exercise | 2,272 | $25.58 | Discretionary |